Amgen Inc. Profile Avatar - Palmy Investing

Amgen Inc.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to tr…
Drug Manufacturers - General
US, Thousand Oaks [HQ]

Balance Sheet

15 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Assets
39,629.00 43,486.00 48,871.00 54,298.00 66,125.00 69,009.00 71,576.00 77,626.00 79,954.00 66,416.00 59,707.00 62,948.00 61,165.00 65,121.00 97,154.00
Current
18,932.00 23,129.00 27,593.00 31,209.00 27,367.00 34,713.00 38,518.00 46,010.00 49,476.00 37,618.00 18,440.00 21,144.00 19,385.00 22,186.00 30,332.00
Non Current
20,697.00 20,357.00 21,278.00 23,089.00 38,758.00 34,296.00 33,058.00 31,616.00 30,478.00 28,798.00 41,267.00 41,804.00 41,780.00 42,935.00 66,822.00
Liabilities
16,962.00 19,542.00 29,842.00 35,238.00 44,029.00 43,231.00 43,493.00 47,751.00 54,713.00 53,916.00 50,034.00 53,539.00 54,465.00 61,460.00 90,922.00
Current
3,873.00 6,570.00 5,754.00 8,103.00 7,947.00 7,008.00 8,667.00 11,204.00 9,020.00 13,488.00 12,835.00 11,653.00 12,184.00 15,687.00 18,392.00
Non Current
13,089.00 12,972.00 24,088.00 27,135.00 36,082.00 36,223.00 34,826.00 36,547.00 45,693.00 40,428.00 37,199.00 41,886.00 42,281.00 45,773.00 72,530.00
Equity
22,667.00 23,944.00 19,029.00 19,060.00 22,096.00 25,778.00 28,083.00 29,875.00 25,241.00 12,500.00 9,673.00 9,409.00 6,700.00 3,661.00 6,232.00
Stockholders' Equity
22,667.00 23,944.00 19,029.00 19,060.00 22,096.00 25,778.00 28,083.00 29,875.00 25,241.00 12,500.00 9,673.00 9,409.00 6,700.00 3,661.00 6,232.00
Retained Earnings
-4,322.00 -3,508.00 -8,919.00 -10,423.00 -7,634.00 -4,624.00 -2,086.00 -438.00 -5,072.00 -17,977.00 -21,330.00 -21,408.00 -24,600.00 -28,622.00 -26,549.00
Common Stock
26,944.00 27,299.00 27,777.00 29,337.00 29,891.00 30,410.00 30,649.00 30,784.00 30,992.00 31,246.00 31,531.00 31,802.00 32,096.00 32,514.00 33,070.00
Preferred Stock
- - - - - - - - - - - - 480.00 - - - - - - - - - - - - - - - -
Profit
4,605.00 4,627.00 3,683.00 4,345.00 5,081.00 5,158.00 6,939.00 7,722.00 1,979.00 8,394.00 7,842.00 7,264.00 5,893.00 6,552.00 6,717.00
Dividends
- - - - -500.00 -1,118.00 -1,415.00 -1,851.00 -2,396.00 -2,998.00 -3,365.00 -3,507.00 -3,509.00 -3,755.00 -4,013.00 -4,196.00 -4,556.00
Minority Interest
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Other Stockholders' Equity
- - - - - - - - - - - - -480.00 - - - - - - - - - - - - - - - -
Loss Other Compr. Income
45.00 153.00 171.00 146.00 -161.00 -8.00 -480.00 -471.00 -679.00 -769.00 -528.00 -985.00 -796.00 -231.00 -289.00
End of AMGN's Analysis
CIK: 318154 CUSIP: 031162100 ISIN: US0311621009 LEI: - UEI: -
Secondary Listings